
    
      -  To assess the dynamic uptake and washout of [123I]MNI-420 in brain using single photon
           emission computed tomography (SPECT) in Parkinson's disease (PD), Huntington's disease
           (HD), and similarly aged healthy subjects as a potential imaging biomarker of adenosine
           receptor type A2a (A2aR) in brain

        -  To acquire initial safety data following injection of [123I]MNI-420
    
  